Foresite Capital Management IV’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.71M | Sell |
816,882
-295,000
| -27% | -$1.7M | 3.81% | 5 |
|
|
2025
Q1 | $7.34M | Sell |
1,111,882
-615,000
| -36% | -$4.06M | 6.61% | 4 |
|
|
2024
Q4 | $15M | Sell |
1,726,882
-123,065
| -7% | -$1.07M | 13.83% | 2 |
|
|
2024
Q3 | $36.1M | Hold |
1,849,947
| – | – | 23.62% | 2 |
|
|
2024
Q2 | $38.1M | Hold |
1,849,947
| – | – | 25.59% | 2 |
|
|
2024
Q1 | $39.5M | Hold |
1,849,947
| – | – | 19.94% | 2 |
|
|
2023
Q4 | $26.6M | Hold |
1,849,947
| – | – | 13.44% | 2 |
|
|
2023
Q3 | $16.9M | Hold |
1,849,947
| – | – | 9.37% | 4 |
|
|
2023
Q2 | $19.6M | Hold |
1,849,947
| – | – | 9.62% | 5 |
|
|
2023
Q1 | $22.6M | Hold |
1,849,947
| – | – | 11.74% | 5 |
|
|
2022
Q4 | $23M | Hold |
1,849,947
| – | – | 9.81% | 5 |
|
|
2022
Q3 | $25.3M | Hold |
1,849,947
| – | – | 8.13% | 4 |
|
|
2022
Q2 | $33.9M | Hold |
1,849,947
| – | – | 9.13% | 5 |
|
|
2022
Q1 | $29.7M | Hold |
1,849,947
| – | – | 8.32% | 5 |
|
|
2021
Q4 | $25.9M | Hold |
1,849,947
| – | – | 5.33% | 7 |
|
|
2021
Q3 | $34.7M | Hold |
1,849,947
| – | – | 5.1% | 7 |
|
|
2021
Q2 | $38.6M | Hold |
1,849,947
| – | – | 5.21% | 6 |
|
|
2021
Q1 | $52.3M | Buy |
1,849,947
+41,965
| +2% | +$1.19M | 6.26% | 7 |
|
|
2020
Q4 | $59M | Buy |
1,807,982
+500,000
| +38% | +$16.3M | 6.41% | 6 |
|
|
2020
Q3 | $40.1M | Hold |
1,307,982
| – | – | 9.04% | 4 |
|
|
2020
Q2 | $21.3M | Buy |
1,307,982
+1,214,982
| +1,306% | +$19.8M | 10.39% | 3 |
|
|
2020
Q1 | $925K | Buy |
93,000
+25,000
| +37% | +$249K | 1.14% | 10 |
|
|
2019
Q4 | $935K | Buy |
+68,000
| New | +$935K | 0.4% | 14 |
|